Lipum

LipUm operates as a biotechnology company that offers anti-inflammatory drugs.

Business Model:

Revenue: $0

Employees: 1-10

Rankings

Detailed Lipum Information

Geographic Data

Lipum headquarters map

Address: Tvistevägen 48C

City: Umeå

State: västerbottens län

Zip: 907 36

Country: SE

Financial Info

Stage:

post ipo equity

Raised Last:

$4M

Raised Total:

$3M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic inflammatory diseases. Lipum has a biological anti-inflammatory drug candidate developed against Rheumatoid Arthritis (RA) – an autoimmune disease characterized by chronic inflammation of the joints. It often causes disability and lowers the quality of life for millions. Lipum also addresses the treatment of Juvenile Idiopathic Arthritis (JIA) that is a rare disease affecting children. A novel biological drug for this disease may be considered for an orphan drug designation. Treatment of other chronic inflammatory conditions is also explored. Related diseases are such as Crohn’s disease, ulcerative colitis, ankylosing spondylitis, and psoriatic arthritis. Lipum&s;s biological anti-inflammatory drug candidate provides a novel mechanism of action. Therefore, it is assumed to have less adverse effects than current treatments in use.

Contact Phone:

Contact Email:

Lipum went public on 4/23/2021 on the Nasdaq OMX Nordic

Listed Exchange:
Nasdaq OMX Nordic

IPO Date:
4/23/2021

Ticker Symbol:
LIPUM

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
9/2022 Post-IPO Equity $0 Flerie Invest
Flerie Invest
5/2022 Grant $1M Swedish Knowledge foundation
8/2016 Seed Round 1 $297.9k Almi Invest
Almi Invest
12/2016 Grant 1 $53.3k EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs
8/2018 Grant $2.4M
4/2021 IPO -
4/2021 IPO -

9/2022 Post-IPO Equity 1 $3.5M Flerie Invest
Flerie Invest
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research